Non-Metastatic Castration-Resistant Prostate Cancer

Also known as: Non-mestatatic castrate-resistant prostate cancer / Castration resistant, nonmetastatic Prostate Cancer / Non-metastatic, castration-resistant prostate cancer / Nonmetastatic Castration-Resistant Prostate Cancer

DrugDrug NameDrug Description
DB11901ApalutamideAn androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer.
DB12941DarolutamideAn androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer.
DrugDrug NamePhaseStatusCount
DB05812Abiraterone1Recruiting1
DB11901Apalutamide1Recruiting1
DB01248Docetaxel1Recruiting1
DB00959Methylprednisolone1Recruiting1
DB00635Prednisone1Recruiting1
DB11853Relugolix1Recruiting1
DB05094Enzalutamide3Active Not Recruiting1
DB08899Enzalutamide3Active Not Recruiting1
DB12941Darolutamide4Recruiting1
DB11901ApalutamideNot AvailableActive Not Recruiting2
DB11901ApalutamideNot AvailableCompleted1
DB12941DarolutamideNot AvailableActive Not Recruiting2
DB12941DarolutamideNot AvailableCompleted1
DB08899EnzalutamideNot AvailableActive Not Recruiting2
DB08899EnzalutamideNot AvailableCompleted1